Glp-1 Analogues for the Treatment of Type 2 Diabetes in Latinos/Hispanics

Whereas race mainly alludes to those physical characteristics that are genetically determined, ethnicity relates to a perceived cultural distinctiveness expressed in language, music, values, art, styles, literature, family life, religion, ritual, food, naming, public life, and culture (2-4). [...]Hi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Endocrine practice 2016-12, Vol.22 (12), p.1459-1461
1. Verfasser: Caballero, A Enrique
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Whereas race mainly alludes to those physical characteristics that are genetically determined, ethnicity relates to a perceived cultural distinctiveness expressed in language, music, values, art, styles, literature, family life, religion, ritual, food, naming, public life, and culture (2-4). [...]Hispanic and Latino are ethnicity-based terms. An interesting cultural concept in this group is that being overweight is not always associated with illness but rather with a state of good health (14). [...]a respectful and thorough discussion about weight goals with patients must take place when introducing therapies that are likely to have an impact on their weight. Of the 3,136 patients included in the various phase 3 clinical trials with dulaglutide at either 0.75 or 1.5 mg per week, 949 were considered as Hispanic/Latinos. [...]almost one in three study participants were Latinos/Hispanics living either in the U.S., in Latin American countries, or Spain. [...]the inherent heterogeneity of the Latino/Hispanic population and other groups will often constitute a challenge in defining race/ethnicity for study participants as well as whether differences in social and cultural aspects not easily addressed in clinical trials may contribute to the response to various pharmacologic treatments in real clinical practice.
ISSN:1530-891X
1934-2403
DOI:10.4158/EP161593.CO